Biotech Market Research
Biotech research lives at the intersection of deep science and capital-intensive commercialisation — neither of which is well served by generic commercial market research. Meraki Research works with biotech companies, academic spin-outs and investor clients across South Africa and international markets, producing research grounded in scientific literacy as well as commercial rigour.
Why Biotech Research Matters
- Biotech commercial decisions sit on top of evolving science — research has to reflect the actual state of the evidence, not last year's narrative.
- Investor and partner due-diligence research requires a standard of rigour most commercial agencies do not deliver.
- South Africa's biotech and biomanufacturing ecosystem — anchored by CSIR, Biovac, the TIA and academic spin-outs — is growing but research coverage is thin.
- SAHPRA pathways for biologics, cell and gene therapies and advanced therapeutic medicinal products shape commercial timelines directly.
- Scientific stakeholder audiences (PIs, translational leads, biotech executives) are small and require respectful, substantive engagement.
Our Biotech Research Services
Scientific and KOL Research
Qualitative research with scientific KOLs, translational researchers and biotech executives, designed and led by researchers with genuine scientific literacy.
Partnering and Licensing Research
Research into partnering and licensing dynamics — what makes deals happen, how terms move, and how African biotech assets are positioned in international conversations.
Investor and Due-Diligence Research
Primary research in support of investor due diligence, covering scientific validation, competitive landscape and commercial feasibility.
Market Opportunity Research
Bottom-up market sizing and demand modelling for specific therapeutic areas or platform technologies, grounded in primary research.
Manufacturing and Supply-Chain Research
Research into biomanufacturing capacity, CDMO selection and supply-chain dynamics, with particular attention to the growing South African biomanufacturing footprint.
Policy and Regulatory Research
Structured research on how regulatory posture — SAHPRA, AMA, FDA, EMA alignment — affects commercial planning and timelines.
How We Approach Research in This Sector
Biotech research requires genuine scientific depth. Our teams include researchers with life-science postgraduate training who can hold credible conversations with principal investigators, translational leaders and biotech executives. We treat published and grey literature as first-order evidence, and we are explicit about the quality of the scientific basis underlying commercial claims.
Why Choose Meraki Research for Biotech?
- Researchers with postgraduate scientific training — not career agency generalists.
- Strong access to South African biotech ecosystem including CSIR, Biovac, university spin-outs and emerging private-sector players.
- Familiarity with SAHPRA biologics pathways and the broader African regulatory harmonisation work.
- Rigour and discipline suited to investor-grade due diligence — no sugar-coating.
What We Deliver
| Deliverable | Format | Typical Timeline |
|---|---|---|
| Scientific KOL Research Report | PDF + clip library | Week 6 |
| Market Opportunity Assessment | PDF + workbook | Week 7 |
| Competitive and Pipeline Landscape | Slide deck + matrix | Week 8 |
| Partnering Landscape Briefing | PDF report | Week 9 |
| Executive Advisory Session | Half-day workshop | Week 9 |